DZ Bank
MLYS icon

DZ Bank’s Mineralys Therapeutics MLYS Stock Holding History

DZ Bank’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Hold
59,242
– – ﹤0.01% 685
2026
Q1 		$1.6M Sell
59,242
-52,511
-47% -$1.54M ﹤0.01% 660
2025
Q4 		$4.06M Buy
+111,753
New +$4.48M ﹤0.01% 543

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DZ Bank's MLYS Position: Q2 2026 in Review

DZ Bank held its Mineralys Therapeutics (MLYS) position steady in Q2 2026 at 59,242 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #685.

DZ Bank first reported a position in MLYS in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.06M in Q4 2025. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • DZ Bank held 59,242 shares of Mineralys Therapeutics worth $1.6M as of Q2 2026.
  • DZ Bank left its Mineralys Therapeutics share count unchanged in Q2 2026.
  • Mineralys Therapeutics made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #685 holding.
  • DZ Bank first reported a position in Mineralys Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • DZ Bank's Mineralys Therapeutics position peaked at $4.06M in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.